Home

The pharmaceutical manufacturer's duty to warn, a comparative study between German and Canadian pharmaceutical products liability laws

Show simple item record

dc.contributor.author Stute, Katrin en_US
dc.date.accessioned 2007-05-18T20:01:48Z
dc.date.available 2007-05-18T20:01:48Z
dc.date.issued 1999-09-01T00:00:00Z en_US
dc.identifier.uri http://hdl.handle.net/1993/1874
dc.description.abstract This thesis presents a comparative analysis of the pharmaceutical manufacturer's duty to instruct the public about inherent product risks, based on German and Canadian liability laws. It shows the development of the case law, as well as the legal and procedural difficulties involved in litigation in both legal systems, by identifying which information the pharmaceutical manufacturer must disclose and showing how to present this to the medical profession and in particular to the consumer, in order to meet requirements and expectations imposed by law, in order to enhance public health and to avoid liability claims. (Abstract shortened by UMI.) en_US
dc.format.extent 19501732 bytes
dc.format.extent 184 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.language en en_US
dc.language.iso en_US
dc.rights info:eu-repo/semantics/openAccess
dc.title The pharmaceutical manufacturer's duty to warn, a comparative study between German and Canadian pharmaceutical products liability laws en_US
dc.type info:eu-repo/semantics/masterThesis
dc.degree.discipline Law en_US
dc.degree.level Master of Laws (LL.M.) en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics